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Xylella fastidiosaXylella fastidiosa is responsible for a wide range of economically important plant diseases. We
report here the crystal structure and kinetic data of Xylellain, the ﬁrst cysteine protease character-
ized from the genome of the pathogenic X. fastidiosa strain 9a5c. Xylellain has a papain-family fold,
and part of the N-terminal sequence blocks the enzyme active site, thereby mediating protein activ-
ity. One novel feature identiﬁed in the structure is the presence of a ribonucleotide bound outside
the active site. We show that this ribonucleotide plays an important regulatory role in Xylellain
enzyme kinetics, possibly functioning as a physiological mediator.
Structured summary of protein interactions:
Xylellain and Xylellain bind by X-ray crystallography (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Xylella fastidiosa is a gram-negative bacteria that colonizes
exclusively the plant xylem vessels decreasing xylem ﬂow compro-
mising the plant development and are difﬁcult (fastidious) to cul-
ture by standard bacteriological procedures [1–3]. Several
economically important crops are affected by X. fastidiosa strains
[4–8] that are transmitted by Homoptera (leafhoppers) insects
[9,10]. In Brazil alone, citrus variegated chlorosis or CVC cause
approximate annual losses to the citrus industry of US $100 million
[11] whose control is limited to crop management, infected
branches pruning and plant eradication. The use of healthy seed-
lings and vector control are at present the only preventive mea-
sures available. The availability in 2000 of the X. fastidiosa clone
9a5c genome sequence [12] lead to a signiﬁcant advance in the
understanding of the bacterium metabolism [2,3]. From X. fastidi-
osa genome analysis a single cysteine protease was identiﬁed,
Xylellain, and characterized as a cathepsin B like protease [13]. In
this study, we solved the crystal structure of Xylellain, to a resolu-tion of 1.65 Å. This structure revealed that the ﬁrst 39 residues of
the enzyme N-terminal sequence are attached to the active site
and represent a regulatory pro-region. Surprisingly a ribonuclotide,
UDP, is present in a hinge region and may play an important role in
stabilizing the N-terminal pro-region, representing a potential en-
zyme activity modulator, sensing the bacteria physiological state.
2. Materials and methods
2.1. Recombinant Xylellain characterization
The expression and puriﬁcation of the recombinant Xylellain
protein was performed essentially as previously described [13]
modiﬁed by the induction temperature reduced to 20 C for 16 h
and isopropyl-b-D-thiogalactopyranoside (IPTG) added to a ﬁnal
concentration of 0.1 mM selenomethionine incorporation for sin-
gle-wavelength anomalous dispersion (SAD) experiments was per-
formed by inhibition of methionine biosynthesis in M9 minimal
medium (Sigma) supplemented by selenomethionine (Sigma) [14].
Point mutations R23A, F25A and R23A/F25A, were generated
using the Gene Tailor™ Site-Directed Mutagenesis kit (Invitrogen),
according to the manufacturer’s instructions and the oligonucleo-
tides: R23A, 50-ATAGCTGATATTGCTGACTTTTCATACACC-30; F25A,
50-GATATTCGTGACGCTTCATACACCCCAGAG-30; R23A/F25A, 50-
ATAGCTGATATTGCTGACGCTTCATACACCCC-30 and their comple-
mentary primer: R23A and R23A/F25A, 50-ATAGGGTCTATATCGAC-
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lain proteins were expressed and puriﬁed as described.
Enzyme kinetic experiments were performed as described [13]
in a WALLAC 1420 ﬂuorimeter using carbobenzoxy-Phe-Arg-7-
amido-4-methylcoumarin (Z-RF-MCA, Sigma) as substrate. The
amount of active enzyme was determined by titration with E64
(N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]-agmatine)
inhibitor [15].
2.2. Crystallization and data collection
Suitable crystals were obtained at 18 C using the hanging-drop
vapor diffusion technique in 60 mM sodium citrate (pH 5.6),
134 mM ammonium acetate and 20–22% (w/v) PEG 4000 and
7 mg/ml of Xylellain. The crystals were cryoprotected in the crys-
tallization solution containing 15% (v/v) ethylene glycol and frozen
to 100 K. A native data set was collected to 1.65 Å resolution, on a
MAR345dtb image-plate detector using Cu Ka radiation generated
by a Rigaku Ultra-X 18 rotating-anode operating at 90 mA and
50 kV and focused using Osmic mirrors. Selenomethionine crystals
were obtained by the hanging-drop vapor diffusion method in
100 mM MES (pH 5.6), 18% PEG 8000 and 6 mg/ml of Xylellain.
Selenomethionine data sets were collected at the National Syn-
chrotron Light Source, Brookhaven National Laboratory, Beamline
X12B. Xylellain diffraction data for the Sel-Met crystal were in-
dexed, integrated and reduced using HKL2000 package [16] while
for the native crystal, the data processing was carried out using
MOSFLM [17]. Intensities were scaled with SCALA from the CCP4
suite [18]. Data collection and processing statistics are provided
in Table 1. Both native and selenomethionine crystals belong to
space group P1 with similar cell dimensions and Matthew’s coefﬁ-
cient [19] calculated to 2.16 Å3/Da with a solvent content of
43.02%.
2.3. Structure solution and reﬁnement
Searches on the PDB database identiﬁed Cathepsin S and F
[20,21] and Cruzain [22] as Xylellain homologues with 30% se-
quence identity. Molecular replacement attempts to solve the
Xylellain structure with AmoRe [23], MOLREP [24] and PHASERTable 1
Crystallographic data collection and reﬁnement statistics
Data set Native
Space group P1
Cell dimensions
a, b, and c (Å) 55.089, 69
a, b, and c (Å) 75.86, 75.
Wavelength (Å) 1.541
Resolution (Å) 78.66–1.6
Rmerge
a (%) 5.4 (40.0)
I/r (I) 9.9 (1.9)
Completeness (%) 91.0 (86.7
Redundancy 8.1 (4.4)
No. of reﬂections observed 117070
No. of reﬂections unique 16,308
Reﬁnement
Number of atoms 8578
Rwork/Rfree (%) 16.85/21.5
r.m.s.d.
Bond angles () 2.082
Bond lengths (Å) 0.025
Ramachandran analysis (%/No.)
Most favored 88.7/800
Additional allowed 10.9/98
General allowed 0.4/4
Numbers in parentheses represent the highest resolutio
a Rmerge =
P
h
P
l=Ihl  hIhi j
P
h
P
l hIhi, where Ihl is
and hIhli are the mean intensity of the h reﬂections. Rmerg[25] were not successful justifying the use of selenomethionine
isomorphous replacement methodology.
The selenomethionine Xylellain structure was solved by SAD
method at the Se-K edge (k = 0.9792). Eight selenium atoms per
cell unit were found using SHELX package [26], initial phases were
obtained with SOLVE [27] and improved by solvent ﬂattening and
density modiﬁcation with 42% solvent content, followed by auto
building routine with RESOLVE [28]. Residues of the initial model
were checked according to their electronic density with COOT
[29]. Initial phases were extended with sequential rounds of sol-
vent ﬂattening and density modiﬁcation using the selenomethio-
nine-containing and native data sets. Cycles of SOLVE–RESOLVE
routine successfully traced and built 665 residues of the expected
1164, with an Rfactor 43% and merit ﬁgure of 0.55. The remaining
model was built manually with COOT followed by reﬁnement with
REFMAC [18]. Water molecules were added by COOT and the struc-
ture was validated using PROCHECK [30]. All pictures were created
using PyMOL [31].
3. Results
3.1. Crystalline packing and overall structure
Both the selenomethionine and the native Xylellain crystals be-
long to the P1 space group, with similar unit cell parameters, con-
taining four Xylellain monomers (chains A–D) (Fig. 1). A contact
surface of 2018 Å2 between chains A/B and C/D is stabilized by po-
lar contacts involving a minimum of 19 residues of each monomer,
13 hydrogen bonds and 6 salt bridges. In this crystal packing the
active site and the propeptide domain belong to the dimer inter-
face in the A/B and C/D chains. The atomic contacts between chains
A/B with C/D is characterized by fewer interactions.
The adopted residue numbering initiates at Met1 from Xylellain
full length sequence (GenBank accession No. AE003869, locus_tag
XF_0156, complement of position 159327–160142). Final reﬁne-
ment shows 1435 waters molecules and a ribonucleotide (UDP)
molecule at each chain.
The ﬁrst 22 and 23 N-terminal amino acid residues of chains A–
D and B–C, respectively, representing the pET28a-derived se-
quence that include the hexahistidine-tag and thrombine site,.
SelMet
P1
.31, 82.36 55.15, 69.21, 82.27
43, 66.51 76.15, 75.67, 66.64
0.972
5 (1.74–1.65) 50.00–1.83 (1.91–1.83)
5.4 (40)
15.1 (2.5)
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–
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–
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–
n bin.
the intensity of the lth observation of reﬂection h
e is computed over all l observations of h reﬂection.
Fig. 1. Cartoon representation of the crystallographic packing of the Xylellain reﬁned structure inside the cell unit. Each monomer, A, B, C and D of Xylellain is represented in
ribbons with a diphosphate ribonucleotide in the ball-and-stick representation near the N-terminal region of each monomer.
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residue (Lys291) are not visible in the electron density maps. No
differences were observed between the unit cell monomers as
shown by the RMSD combinantion of structural superpositions
0.41 Å (AB); 0.43 Å (AC); 0.22 Å (AD); 0.29 Å (BC); 0.44 Å (BD);
0.43 Å (CD). The overall fold of Xylellain shows a core structure
characteristic of the papain-like cysteine protease family [32] with
a two domain arrangement, a predominantly a-helix N-terminal
domain and a predominantly b-sheet C-terminal domain. The ac-
tive site cleft is located at the domains interface.
3.2. The active-site cleft and N-terminal extension
The Xylellain active site is homologous to the papain family cys-
teine proteases, forming a cleft where the substrate peptide is ﬁt-
ted. The papain active site consists of seven subsites (S4, S3, S2, S1,
S10, S20, S30 and S40) that interact with seven amino acids (P4, P3,
P2, P1, P10, P20, P30 and P40) of the substrate peptide (Fig. 2). Xylel-
lain active site is characterized by four residues, Gln72, Cys78,
Hys237 and Asn255, where Cys78, located at the N-terminal helix
a2, and Hys237 located at the strand b4 form the catalytic dyad.
Gln72 precedes the catalytic (Cys78) and is responsible for the for-
mation of the oxy-anion pocket during the peptide bond hydroly-
sis. Asn255, acts correctly positioning the imidazole ring of His217
through a hydrogen bond between the Ne2 of His237and Od1 of
Gln72. The active site cleft is blocked by the N-terminal sequence
(Lys29 to Ile39) analogous to other papain family cysteine prote-
ases [33].
Xylellain structure reveals an interesting N-terminal amino
acids region close to the substrate binding site. The ﬁrst segment
(I) of the proregion (Thr23 to Arg28) does not interact directly with
the protein. While a second segment (II) of ten residues (Lys29 to
Ile39) is buried within the active site cleft, between the two protein
domains forming a 990 Å2 surface of interaction. The two segments
(I and II) are separated by two residues, Gly32 and Gly34, enabling
segment I to twist approximately 70 degrees relative to segment IIover the active site cleft. Segment II is stabilized by eigth hydrogen
bonds (NnLys30-OSer122-3.02 Å, Ne1Trp284-Od2Asp38-2.83 Å;
NAsp38-Od2Asp282-3.06 Å; NIle36-OAla124-2.97 Å; NeArg43-
Od1Asp41-2.87 Å; NH1Arg43-Od2Asp41-2.71 Å; NH2Arg186-
Od2Asp38-2.8 Å; NH1Arg127-OIle39-2.93 Å) and amino acids
Ser31, Tyr33, Tyr35, Ile36, Asp38 side chains interact with S20,
S10, S1, S2 and S3 sites respectively [34] as seen in procathepsins
B, K, L and Caricain [35–37]. The proregion hydrolysis is avoided
by its positioning in the reverse direction in regard to the substrate
peptide [38].
3.3. Ribonucleotide UDP
During the process of structure reﬁnement, an unaccounted
electron density was observed close to the helix a4 and strand
b3 and the proregion residues Asp41, Arg43 and Phe45 in all four
chains of the asymmetric unit. After careful analysis this electron
density was identiﬁed to a ribonucleotide and the electron density
contour at carbon C20 of the ribonucleotide pentose ring estab-
lished that it is a ribose. The two pyrimidine ribonucleotide
diphosphate, cytosine and uracil, can be modeled within this elec-
tron density and neither the monophosphate nor the triphosphate
ribonucleotide satisfy the density map as well as the diphosphate.
Analysis of the interactions between the ribonucleotide pyrimidine
ring and Xylellain side chains suggests that the C4 oxygen of uracil
can satisfy a hydrogen bond with the nitrogen of Tyr184 backbone,
while the cytosine C4 nitrogen will not form such a bond. From
these observations we propose that the nucleotide is a uridine
diphosphate (UDP). An electron density omit map for the UDP is
shown in Fig. 3. The UDP binding pocket is formed by Asp41,
Arg43, Asp44, Phe45 and Lys131, Lys135, Tyr184. The ﬁrst four
from the proregion, Lys131 and Lys135 from helix a4 and Tyr184
from strand b3 (Fig. 3). The UDP pyrimidine ring is stacked be-
tween Phe45 and Tyr184 aromatic rings, hydrogen bonds are ob-
served between the UDP O2 and O4 and the main chain nitrogen
of Phe45 and Tyr184, respectively, and also between the N3 with
Fig. 2. Representation of the surface of Xylellain, showing the interaction between the proregion (red cartoon and yellow sticks) and the proregion-binding sites, S10 (green),
S20 (blue), S1 (orange), S2 (magenta) and S3 (yellow). Stick representations show residues complementary to the substrate-binding site.
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groups of UDP are accommodated by Lys131 and Lys135 from helix
a4 and Arg43 from the proregion (Fig. 3).
The role of UDP in Xylellain is an intriguing topic. To our knowl-
edge this is the ﬁrst time a ribonucleotide is found in a protease. In
an attempt to address its role, residues Arg43 and Phe45 were
substituted for Ala by site-directed mutagenesis, generating the
Xylellain Arg43Ala, Phe45Ala and the double mutant Arg43Ala/
Phe45Ala and their kinetic parameters were compared with the
native Xylellain (Table 2).
Comparison of the kinetic results indicate a more signiﬁcant
alteration of the km values from the native Xylellain for the double
mutant Arg43Ala/Phe45Ala = 28(1) lM and the single mutant
Phe45Ala = 124,6(9) lM, than the observed effect of the mutations
on the kcat/km values, that remain mostly constant and within the
experimental error (Table 2).
4. Discussion
4.1. Structure of Xylellain
Xylellain shares a common fold with other cystein proteases.
The 39 amino acid residues representing Xylellain propeptide isanalogous to other cystein proteases, like catepsin B (3PBH), K
(7PCK) and L (1BY8) [35,36] although shorter. Cystein proteases
proregion form extensive contacts with a loop and a b-strand re-
gion on the protein surface, forming a structure called ‘‘Prore-
gion Binding Loop’’ (PBL) [39]. These proregions are
accommodated in the active site cleft mimicking the substrate
interactions with the catalytic residues, however, self-cleavage
is inhibited by its reverse orientation in relation to the substrate.
The proregion can be divided in two segments (I and II). Seg-
ment I (Thr23 to Arg28) is free of the active site and could be
a cellular signal sequence, while segment II (Lys29 to Ile39) ﬁts
in the active site and is stabilized by seven hydrogen bonds
(Fig. 2) and Ser21, Tyr23, Tyr25, Ile26, Asp28 interaction with
S20, S10, S1, S2 and S3 sites (Fig. 2).
One intriguing and novel aspect of this structure is the presence
of a bound UDP. The pyrimidine ring identity was determined by
the UDP ﬁtting in the electron density map. The Xylellain side
chains residues interaction with the pyrimidine ring show that
uracil C4 oxygen satisﬁes the hydrogen bond with Tyr184 nitrogen,
strengthening our initial identiﬁcation. Citosine C4 nitrogen would
not form such a hydrogen bond.
The UDP binding pocket location, at the bent of the proregion
leaving the active site cleft, decreases the ﬂexibility of this region
Fig. 3. UDP molecule interaction and identiﬁcation. A r-weighted 2 Fo – Fc omit electron-density map is shown contoured at 1.0r for the area surrounding the ligand (UDP).
A hydrophobic pocket is formed by residues Phe45 and Tyr184 interacting the nitrogen base of UDP. Hydrogen bonds complement the nucleotide binding pocket. Positively
charged residues Arg43, Lys131 and Lys135 form a large charged surface that interacts with the negatively charged phosphates of UDP. A hydrogen-bonding network (Asp41-
Arg43, Asp44-Arg141) maintains the N-terminal proregion near the protein core.
Table 2
Comparison of enzyme kinetics between native and mutant Xylellain.
km (lM) kcat/km (1/mM1 s1)
Native Xylellain 69 ± 6 0.22 ± 0.2
Mutant Arg43Ala 35 ± 4 0.12 ± 0.1
Mutant Phe45Ala 124.6 ± 9 0.33 ± 0.3
Mutant Arg43Ala/Phe45Ala 28 ± 1 0.25 ± 0.2
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pared to the overall structure of 22.8 Å2. The position and the
strong interactions of UDP with the proregion suggest a contribu-
tion to the N-terminal sequence ﬁtting in the active site cleft.
The kinetic data (Table 2) revealed that mutations in the UDP
binding pocket, that prevent the ribonucleotided stabilization, re-
sulted in a strong km variation for the substrate, but maintain the
kcat/km values, suggesting that the UDP inﬂuences the substrate
accessibility to the active site cleft not affecting catalytic efﬁciency
(Table 2).
We hypothesize that UDP acts as a physiological regulator of
the activation of Xylellain. Destabilization of this nucleotide as a
result of cell signaling events would cause segment II of the prore-
gion to lose its interaction with the cleft surface and leave the ac-
tive site more exposed and accessible to the substrate. In contrast,
in the presence of UDP, segment II would interact perfectly with
the active site, preventing unwanted proteolysis. Our ﬁndings sug-
gest a novel mechanism for the regulation of the activation of cys-
teine proteases.
4.2. Protein data bank accession code
Protein coordinates and structure factors were deposited on
RCSB protein data bank under PDB code 3OIS.Acknowledgements
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